Brief: Bergenbio Q4 Operating Loss Widens To NOK 59.1 Million

Oncoinvent ASA

11/02/2020 06:06

Feb 11 (Reuters) - Bergenbio ASA  BGBIO.OL :
    * : RESULTS FOR THE FOURTH QUARTER AND FULL YEAR 2019
    * Q4 OPERATING  LOSS NOK 59.1 MILLION VERSUS LOSS NOK 50.9
MILLION
YEAR AGO
    * Q4 OPERATING REVENUE NOK 0.2 MILLION VERSUS NOK 2.3
MILLION YEAR
AGO

Source text for Eikon:  ID:nWkr1BbKk8 
Further company coverage:  BGBIO.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 587785110;))